Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance

H Haozhe Huang (Zhejiang Cancer Hospital, Zhejiang Provincial Key Laboratory of Protein Detection Technology and Diagnostic Equipment, Hangzhou Institute of Medicine, Chinese Academy of Sciences) Y Yiqing Mu Y Yixian Huang B Beihong Ji Y Yifei Wang C Chien-Yu Chen Y Yuang Chen Z Zhangyi Luo (Department of Bioengineering, University of Pennsylvania) S Sihan Li (Division of Ribonucleic Acid (RNA) and Gene Regulation, Institute of Medical Science, The University of Tokyo) Z Ziqian Zhang L Luxuan Wang J James F. Conway D Da Yang J Junmei Wang (Department of Pharmaceutical Sciences, School of Pharmacy) J Jingjing Sun S Song Li